Literature DB >> 33353947

Structure of the dopamine D2 receptor in complex with the antipsychotic drug spiperone.

Dohyun Im1, Asuka Inoue2,3,4, Takaaki Fujiwara1,5, Takanori Nakane6,7, Yasuaki Yamanaka1, Tomoko Uemura1, Chihiro Mori1, Yuki Shiimura1,8, Kanako Terakado Kimura1, Hidetsugu Asada1, Norimichi Nomura1, Tomoyuki Tanaka1,9, Ayumi Yamashita1,9, Eriko Nango9,5, Kensuke Tono10, Francois Marie Ngako Kadji2, Junken Aoki2,4,11, So Iwata12,13, Tatsuro Shimamura14.   

Abstract

In addition to the serotonin 5-HT2A receptor (5-HT2AR), the dopamine D2 receptor (D2R) is a key therapeutic target of antipsychotics for the treatment of schizophrenia. The inactive state structures of D2R have been described in complex with the inverse agonists risperidone (D2Rris) and haloperidol (D2Rhal). Here we describe the structure of human D2R in complex with spiperone (D2Rspi). In D2Rspi, the conformation of the extracellular loop (ECL) 2, which composes the ligand-binding pocket, was substantially different from those in D2Rris and D2Rhal, demonstrating that ECL2 in D2R is highly dynamic. Moreover, D2Rspi exhibited an extended binding pocket to accommodate spiperone's phenyl ring, which probably contributes to the selectivity of spiperone to D2R and 5-HT2AR. Together with D2Rris and D2Rhal, the structural information of D2Rspi should be of value for designing novel antipsychotics with improved safety and efficacy.

Entities:  

Year:  2020        PMID: 33353947     DOI: 10.1038/s41467-020-20221-0

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  50 in total

Review 1.  Molecular effects of dopamine on striatal-projection pathways.

Authors:  C R Gerfen
Journal:  Trends Neurosci       Date:  2000-10       Impact factor: 13.837

2.  Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics.

Authors:  P Sokoloff; B Giros; M P Martres; M L Bouthenet; J C Schwartz
Journal:  Nature       Date:  1990-09-13       Impact factor: 49.962

Review 3.  Parkinson's disease. First of two parts.

Authors:  A E Lang; A M Lozano
Journal:  N Engl J Med       Date:  1998-10-08       Impact factor: 91.245

Review 4.  Parkinson's disease. Second of two parts.

Authors:  A E Lang; A M Lozano
Journal:  N Engl J Med       Date:  1998-10-15       Impact factor: 91.245

Review 5.  Dopamine receptors: from structure to function.

Authors:  C Missale; S R Nash; S W Robinson; M Jaber; M G Caron
Journal:  Physiol Rev       Date:  1998-01       Impact factor: 37.312

6.  Cloning of the cDNA and gene for a human D2 dopamine receptor.

Authors:  D K Grandy; M A Marchionni; H Makam; R E Stofko; M Alfano; L Frothingham; J B Fischer; K J Burke-Howie; J R Bunzow; A C Server
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

7.  Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.

Authors:  I Creese; D R Burt; S H Snyder
Journal:  Science       Date:  1976-04-30       Impact factor: 47.728

Review 8.  Multiple classes of dopamine receptors in mammalian central nervous system: the involvement of dopamine-sensitive adenylyl cyclase.

Authors:  J W Kebabian
Journal:  Life Sci       Date:  1978-08-07       Impact factor: 5.037

9.  The role of brain dopamine in behavioral regulation and the actions of psychotropic drugs.

Authors:  S H Snyder; K M Taylor; J T Coyle; J L Meyerhoff
Journal:  Am J Psychiatry       Date:  1970-08       Impact factor: 18.112

Review 10.  The dopamine hypothesis of schizophrenia: version III--the final common pathway.

Authors:  Oliver D Howes; Shitij Kapur
Journal:  Schizophr Bull       Date:  2009-03-26       Impact factor: 9.306

View more
  11 in total

1.  Structure-based design of a novel third-generation antipsychotic drug lead with potential antidepressant properties.

Authors:  Zhangcheng Chen; Luyu Fan; Huan Wang; Jing Yu; Dengyu Lu; Jianzhong Qi; Fen Nie; Zhipu Luo; Zhen Liu; Jianjun Cheng; Sheng Wang
Journal:  Nat Neurosci       Date:  2021-12-09       Impact factor: 24.884

Review 2.  "Selective" serotonin 5-HT2A receptor antagonists.

Authors:  Austen B Casey; Meng Cui; Raymond G Booth; Clinton E Canal
Journal:  Biochem Pharmacol       Date:  2022-04-04       Impact factor: 6.100

3.  Evolutionary association of receptor-wide amino acids with G protein-coupling selectivity in aminergic GPCRs.

Authors:  Berkay Selçuk; Ismail Erol; Serdar Durdağı; Ogün Adebali
Journal:  Life Sci Alliance       Date:  2022-05-25

4.  Ligand-directed bias of G protein signaling at the dopamine D2 receptor.

Authors:  Ee Von Moo; Kasper Harpsøe; Alexander S Hauser; Ikuo Masuho; Hans Bräuner-Osborne; David E Gloriam; Kirill A Martemyanov
Journal:  Cell Chem Biol       Date:  2021-07-23       Impact factor: 8.116

Review 5.  Potential Mechanisms for Why Not All Antipsychotics Are Able to Occupy Dopamine D3 Receptors in the Brain in vivo.

Authors:  Béla Kiss; Balázs Krámos; István Laszlovszky
Journal:  Front Psychiatry       Date:  2022-03-24       Impact factor: 4.157

6.  An original approach to measure ligand/receptor binding affinity in non-purified samples.

Authors:  Estelle Rascol; Anouk Dufourquet; Rim Baccouch; Pierre Soule; Isabel D Alves
Journal:  Sci Rep       Date:  2022-03-30       Impact factor: 4.379

7.  Dissecting the Mechanism of Action of Spiperone-A Candidate for Drug Repurposing for Colorectal Cancer.

Authors:  Annamaria Antona; Marco Varalda; Konkonika Roy; Francesco Favero; Eleonora Mazzucco; Miriam Zuccalà; Giovanni Leo; Giulia Soggia; Valentina Bettio; Martina Tosi; Miriam Gaggianesi; Beatrice Riva; Simone Reano; Armando Genazzani; Marcello Manfredi; Giorgio Stassi; Davide Corà; Sandra D'Alfonso; Daniela Capello
Journal:  Cancers (Basel)       Date:  2022-02-02       Impact factor: 6.639

Review 8.  Fentanyl Structure as a Scaffold for Opioid/Non-Opioid Multitarget Analgesics.

Authors:  Piotr F J Lipiński; Joanna Matalińska
Journal:  Int J Mol Sci       Date:  2022-03-02       Impact factor: 5.923

9.  Identification of Novel Dopamine D2 Receptor Ligands-A Combined In Silico/In Vitro Approach.

Authors:  Lukas Zell; Constanze Lainer; Jakub Kollár; Veronika Temml; Daniela Schuster
Journal:  Molecules       Date:  2022-07-11       Impact factor: 4.927

Review 10.  Recent Advances in Structure, Function, and Pharmacology of Class A Lipid GPCRs: Opportunities and Challenges for Drug Discovery.

Authors:  R N V Krishna Deepak; Ravi Kumar Verma; Yossa Dwi Hartono; Wen Shan Yew; Hao Fan
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.